Benzodiazepine Receptor Quantification in vivo in Humans Using [11C]Flumazenil and PET: Application of the Steady-State Principle
暂无分享,去创建一个
J. S. Duncan | D. R. Turton | N. Lassen | A. Lammertsma | S. Luthra | S. Osman | J. Duncan | A. Lammertsma | T. Jones | P. Bloomfield | D. Turton | P. Patsalos | M. Prevett | M. T. O'Connell | A. A. Lammertsma | M. C. Prevett | P. Patsalos | T. Jones | S. Osman | N. A. Lassen | P. A. Bartenstein | S. K. Luthra | P. M. Bloomfield | P. N. Patsalos | J. Vanggaard Andersen | M. O’Connell | J. V. Andersen | J. Duncan | P. Bartenstein | N. Lassen | Terry Jones
[1] M. Iyo,et al. Quantitative in vivo analysis of benzodiazepine binding sites in the human brain using positron emission tomography , 1991, Neuropharmacology.
[2] Bernard Bendriem,et al. Modeling Analysis of [11C]Flumazenil Kinetics Studied by PET: Application to a Critical Study of the Equilibrium Approaches , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] Peter Herscovitch,et al. Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to [18F]Cyclofoxy and Positron Emission Tomography , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] W. Wisden,et al. Function and pharmacology of multiple GABAA receptor subunits. , 1991, Trends in pharmacological sciences.
[5] Karl J. Friston,et al. Localisation in PET Images: Direct Fitting of the Intercommissural (AC—PC) Line , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] J. Baron,et al. Regional Specific Binding of [11C]RO 15 1788 to Central Type Benzodiazepine Receptors in Human Brain: Quantitative Evaluation by PET , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] D E Kuhl,et al. Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] N. Lassen,et al. Tracer kinetic methods in medical physiology , 1979 .
[9] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[10] Christer Halldin,et al. Saturation analysis of specific 11C Ro 15‐1788 binding to the human neocortex using positron emission tomography , 1989 .
[11] D Comar,et al. Synthesis of ethyl 8-fluoro-5,6-dihydro-5-[11C]methyl-6-oxo-4H-imidazo [1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography. , 1984, The International journal of applied radiation and isotopes.
[12] S. Woods,et al. Receptor binding characterization of the benzodiazepine radioligand 125I-Ro16-0154: potential probe for SPECT brain imaging. , 1990, Life sciences.
[13] M. Phelps,et al. Effects of Temporal Sampling, Glucose Metabolic Rates, and Disruptions of the Blood—Brain Barrier on the FDG Model with and without a Vascular Compartment: Studies in Human Brain Tumors with PET , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] A. Nordberg,et al. Neuroreceptor changes in Alzheimer disease. , 1992, Cerebrovascular and brain metabolism reviews.
[15] D E Kuhl,et al. Differentiation of Radioligand Delivery and Binding in the Brain: Validation of a Two-Compartment Model for [11C]Flumazenil , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] D. R. Turton,et al. An automated system based on solid phase extraction and HPLC for the routine determination in plasma of unchanged carbon-11 L-deprenyl Carbon-11 diprenorphine; carbon-11 flumazenil; Carbon-11 raclopride and Carbon-11 Scherring 23390 , 1993 .
[17] R. Frackowiak,et al. Measurement of Cerebral Monoamine Oxidase B Activity Using L-[11C]Deprenyl and Dynamic Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] M. Memo,et al. The differences in the pharmacological profiles of various benzodiazepine recognition site ligands may be associated with GABAA receptor structural diversity. , 1990, Advances in biochemical psychopharmacology.
[19] A. Mans,et al. Regional Distribution and Kinetics of Three Sites on the GABAA Receptor: Lack of Effect of Portacaval Shunting , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] T J Spinks,et al. Physical performance of a positron tomograph for brain imaging with retractable septa. , 1992, Physics in medicine and biology.
[21] N. Lassen,et al. Neuroreceptor Quantitation in vivo by the Steady-State Principle Using Constant Infusion or Bolus Injection of Radioactive Tracers , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] J. Baron,et al. Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomography. , 1992, European journal of pharmacology.